Project Details
Description
A Phase II Study of Lapatinib for Brain Metastases in Subjects with ErbB2-Positive Breast Cancer Following Trastuzumab-based Systemic Therapy and Cranial Radiotherapy
| Status | Finished |
|---|---|
| Effective start/end date | 11/22/05 → 11/1/09 |
Funding
- GLAXOSMITHKLINE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.